50 results on '"Bringmann, Peter"'
Search Results
2. Blockade of placental growth factor reduces vaso-occlusive complications in murine models of sickle cell disease
3. Data from Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate Cancer
4. Color version of Fig. 3 from Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate Cancer
5. P-43 Inactivation des pathogènes et qualité des CGR traités par amustaline
6. Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides
7. Comparison of Bacterial Risk in Cryo AHF and Pathogen Reduced Cryoprecipitated Fibrinogen Complex
8. Inactivation of SARS-CoV-2 in All Blood Components Using Amotosalen/Ultraviolet A Light and Amustaline/Glutathione Pathogen Reduction Technologies
9. Robust inactivation of Plasmodium falciparum in red blood cell concentrates using amustaline and glutathione pathogen reduction
10. Inactivation de Lactobacillus delbrueckii et Citrobacter koseri par amotosalen-UVA
11. Inactivation d’un large spectre d’agents pathogènes dans des plaquettes IA
12. Inactivation d’un large spectre d’agents pathogènes dans le plasma IA
13. Characterization of virus-like particle assembly for DNA delivery using asymmetrical flow field-flow fractionation and light scattering
14. Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction
15. Inactivation of a broad spectrum of viruses and parasites by photochemical treatment of plasma and platelets using amotosalen and ultraviolet A light
16. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage
17. Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction.
18. Site-specific modification of ED-B-targeting antibody using intein-fusion technology
19. Des technologies ciblant les acides nucléiques inactivent des niveaux élevés de Plasmodium falciparum dans tous les composants sanguins
20. Inactivation robuste de la souche vaccinale 17D du virus de la fièvre jaune par traitement photochimique des concentrés plaquettaires
21. Purification of small nuclear ribonucleoprotein particles with antibodies against modified nucleosides of small nuclear RNAs
22. FIS is a regulator of metabolism in Escherichia coli
23. Investigation of the binding interactions of progesterone using muteins of the human progesterone receptor ligand binding domain designed on the basis of a three-dimensional protein model
24. Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia
25. Potential Mitigation of the Covert Risk of Bacterial Contamination of RBC: Inactivation of Propionibacterium Acnes in RBC Using Amustaline and Glutathione
26. Site-specific modification of ED-B-targeting antibody using intein-fusion technology
27. Tab2, a novel recombinant polypeptide tag offering sensitive and specific protein detection and reliable affinity purification
28. High levels of protein expression using different mammalian CMV promoters in several cell lines
29. Identification of a Novel Prostate Tumor Target, Mindin/RG-1, for Antibody-Based Radiotherapy of Prostate Cancer
30. Cloning and characterization of the rat HIF-1α prolyl-4-hydroxylase-1 gene
31. Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system
32. Fibrin selectivity of the isolated protease domains of tissue‐type and vampire bat salivary gland plasminogen activators
33. 156 Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single chain human tPA and vampire bat plasminogen activator
34. O-Linked L-Fucose Is Present in Desmodus rotundus Salivary Plasminogen Activator
35. Structural Features Mediating Fibrin Selectivity of Vampire Bat Plasminogen Activators
36. Plasmhogen Activators from the Saliva of Desmodus rotundus (Common Vampire Bat): Unique Fibrin Specificity
37. High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells
38. The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundas: cloning and expression
39. Characterisation of human and murine snRNP proteins by two-dimensional gel electrophoresis and phosphopeptide analysis of U1-specific 70K protein variants.
40. A monoclonal antibody against 2,2,7-trimethylguanosine that reacts with intact, class U, small nuclear ribonucleoproteins as well as with 7-methylguanosine-capped RNAs.
41. Isolation and characterization of rabbit anti-m3G antibodies.
42. Antibodies specific for N6‐methyladenosine react with intact snRNPs U2 and U4/U6
43. Thrombolytic Properties of Desmodus rotundus(vampire bat) Salivary Plasminogen Activator in Experimental Pulmonary Embolism in Rats
44. O-Linked L-Fucose Is Present in Desmodus rotundusSalivary Plasminogen Activator (∗)
45. 5′-terminal caps of snRNAs are reactive with antibodies specific for 2,2,7-trimethylguanosine in whole cells and nuclear matrices
46. Potential Mitigation of the Covert Risk of Bacterial Contamination of RBC: Inactivation of Propionibacterium Acnesin RBC Using Amustaline and Glutathione
47. Long-Acting, Oxidation-Resistant IL-33 Mobilizes High-Quality Hematopoietic Stem and Progenitor Cells More Efficiently Than Wild-Type IL-33, G-CSF or AMD3100
48. Thrombolytic Properties of Desmodus rotundus (vampire bat) Salivary Plasminogen Activator in Experimental Pulmonary Embolism in Rats
49. Establishment of transfusion-relevant bacteria reference strains for red blood cells.
50. Cloning and characterization of the rat HIF-1 alpha prolyl-4-hydroxylase-1 gene.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.